Every record from Janoshik · page 10
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041656 | Semaglutide | QSC | QSC-2511-M9226 | 2026-Q2 | 99.67 | 4.04 | 94.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041497 | Kisspeptin-10 | QYB | QYB-2512-X5662 | 2026-Q2 | 99.45 | 4.45 | 88.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041285 | Semaglutide | WWB | WWB-2603-N3120 | 2026-Q2 | 98.67 | 7.21 | 96.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043009 | Tirzepatide | KP | KP-2602-X5446 | 2026-Q2 | 98.77 | 6.59 | 99.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041657 | Semaglutide | QSC | QSC-2511-M9226 | 2026-Q2 | 99.53 | 3.84 | 97.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043386 | TB-500 | CPC | CPC-2603-C3192 | 2026-Q2 | 98.23 | 5.80 | 96.0 | Supplier-supplied | 1 | FAIL |
| AX-2026-043016 | Semaglutide | KP | KP-2511-J4998 | 2026-Q2 | 99.01 | 7.94 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2026-042523 | Liraglutide | ERP | ERP-2601-P6802 | 2026-Q2 | 98.45 | 4.85 | 94.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042343 | BPC-157 | HJ | HJ-2511-U3414 | 2026-Q2 | 98.87 | 5.01 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042095 | PT-141 (Bremelanotide) | TFC | TFC-2512-V7681 | 2026-Q2 | 99.07 | 2.93 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041889 | Melanotan II | JEEP | JEEP-2604-R3923 | 2026-Q2 | 99.57 | 4.98 | 104.5 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041710 | Exenatide | QSC | QSC-2602-P9435 | 2026-Q2 | 99.32 | 4.84 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043238 | Melanotan II | SGN | SGN-2602-L1809 | 2026-Q2 | 99.01 | 2.84 | 99.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043150 | MOTS-c | SSA | SSA-2511-W7415 | 2026-Q2 | 98.33 | 5.76 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042985 | Desmopressin | KP | KP-2512-U5139 | 2026-Q2 | 98.46 | 2.18 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-042934 | Semaglutide | MKM | MKM-2601-Y3343 | 2026-Q2 | 97.36 | 3.70 | 104.6 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042868 | BPC-157 | GGPeps | GGPE-2512-G2285 | 2026-Q2 | 98.53 | 3.93 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042470 | Semaglutide | SWB | SWB-2603-T5632 | 2026-Q2 | 98.33 | 6.27 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042441 | IGF-1 DES (1-3) | SWB | SWB-2601-Y5870 | 2026-Q2 | 98.55 | 4.26 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042410 | MK-677 (Ibutamoren mesylate) | SWB | SWB-2605-B4738 | 2026-Q2 | 99.61 | 2.81 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-041223 | Thymulin | WWB | WWB-2602-S2129 | 2026-Q2 | 99.17 | 3.78 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043267 | GHK-Cu | CPC | CPC-2601-D2294 | 2026-Q2 | 98.39 | 7.18 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043217 | SLU-PP-332 | SGN | SGN-2602-X9969 | 2026-Q2 | 97.74 | 6.22 | 96.5 | Buyer-sourced | 0 | FAIL |
| AX-2026-041765 | MK-677 (Ibutamoren mesylate) | FGP | FGP-2604-K1470 | 2026-Q2 | 99.93 | 5.08 | — | Supplier-supplied | 0 | FAIL |
| AX-2026-043298 | IGF-1 LR3 | CPC | CPC-2512-S2394 | 2026-Q2 | 97.28 | 2.61 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041749 | Cagrilintide | FGP | FGP-2602-M9870 | 2026-Q2 | 99.47 | 4.14 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041352 | BPC-157 | WWB | WWB-2604-B3510 | 2026-Q2 | 99.89 | 5.00 | 90.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043275 | Hexarelin | CPC | CPC-2511-F1491 | 2026-Q2 | 98.77 | 4.43 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-043252 | BPC-157 | SGN | SGN-2512-H1950 | 2026-Q2 | 98.19 | 4.87 | 99.3 | Buyer-sourced | 2 | MARGINAL |
| AX-2026-042961 | Retatrutide | KP | KP-2604-N4308 | 2026-Q2 | 98.29 | 5.67 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2026-041821 | PT-141 (Bremelanotide) | FGP | FGP-2602-Y1702 | 2026-Q2 | 99.42 | 4.15 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043448 | BPC-157 | WXT | WXT-2602-W4680 | 2026-Q2 | 98.40 | 4.68 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043119 | Mazdutide | SSA | SSA-2605-G6781 | 2026-Q2 | 99.28 | 2.75 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042866 | BPC-157 | GGPeps | GGPE-2512-G2285 | 2026-Q2 | 98.11 | 3.95 | 105.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042747 | N-Acetyl Semax Amide | GGPeps | GGPE-2512-A1206 | 2026-Q2 | 98.25 | 7.00 | — | Buyer-sourced | 1 | FAIL |
| AX-2026-042582 | SLU-PP-332 | GGPeps | GGPE-2511-R8569 | 2026-Q2 | 98.98 | 4.56 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043183 | PT-141 (Bremelanotide) | GL Biochem | GLBI-2511-F8417 | 2026-Q2 | 97.84 | 1.92 | — | Supplier-supplied | 2 | FAIL |
| AX-2026-042699 | Retatrutide | GGPeps | GGPE-2512-D9394 | 2026-Q2 | 98.74 | 3.89 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041607 | Pinealon | QSC | QSC-2602-V8219 | 2026-Q2 | 99.93 | 7.46 | — | Supplier-supplied | 0 | FAIL |
| AX-2026-042855 | Retatrutide | GGPeps | GGPE-2601-C2423 | 2026-Q2 | 98.08 | 4.35 | — | Supplier-supplied | 1 | MARGINAL |